Tofflon Science and Technology Group Co., Ltd. (SHE:300171)

China flag China · Delayed Price · Currency is CNY
16.48
-0.03 (-0.18%)
At close: Mar 6, 2026
Market Cap12.54B +24.7%
Revenue (ttm)5.22B +8.7%
Net Income172.92M +2.0%
EPS0.23 +4.7%
Shares Out760.85M
PE Ratio71.03
Forward PE109.87
Dividend0.06 (0.36%)
Ex-Dividend DateSep 25, 2025
Volume6,374,962
Average Volume9,278,106
Open16.41
Previous Close16.51
Day's Range16.41 - 16.71
52-Week Range10.60 - 20.37
Beta0.40
RSI44.72
Earnings DateApr 29, 2026

About SHE:300171

Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. It operates through four segments: Biotechnology, Preparation Equipment, Engineering, and Food Engineering. The company offers technological research, such as cell technology, complex preparation, injection, and OSD laboratory; instruments, including cell therapy and nucleic acid drugs instruments, and table reactor; cryopreservation system for seeds and biological samples... [Read more]

Sector Healthcare
Founded 1993
Employees 5,417
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300171
Full Company Profile

Financial Performance

In 2024, SHE:300171's revenue was 5.01 billion, a decrease of -11.19% compared to the previous year's 5.64 billion. Earnings were 194.09 million, a decrease of -67.66%.

Financial Statements